Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6525
    +0.0025 (+0.39%)
     
  • OIL

    83.02
    +0.21 (+0.25%)
     
  • GOLD

    2,335.60
    -2.80 (-0.12%)
     
  • Bitcoin AUD

    98,135.33
    -4,224.22 (-4.13%)
     
  • CMC Crypto 200

    1,385.35
    +2.78 (+0.20%)
     
  • AUD/EUR

    0.6084
    +0.0013 (+0.22%)
     
  • AUD/NZD

    1.0950
    +0.0008 (+0.07%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,078.71
    +38.33 (+0.48%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    18,004.46
    -84.24 (-0.47%)
     
  • Hang Seng

    17,265.69
    +64.42 (+0.37%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

Pfizer and BioNTech Vaccine Sales Jump $1.4 Billion Thanks to AstraZeneca's Blunders

Pfizer and BioNTech Vaccine Sales Jump $1.4 Billion Thanks to AstraZeneca's Blunders

The European Commission exercised its option to buy these doses under an existing agreement signed in February. This move brings the total doses the two companies are supplying to EU members to 600 million. From early on in the race to develop a COVID-19 vaccine, AstraZeneca seemed destined to be the top player in Europe.